Presently, Jerel A. Banks occupies the position of Chairman & Chief Executive Officer for Benitec Biopharma, Inc., Executive Chairman & Chief Executive Officer of Benitec Biopharma Pty Ltd. and Chief Executive & Financial Officer & Secretary at Tacere Therapeutics, Inc. (both are subsidiaries of Benitec Biopharma, Inc.) and Chief Investment Officer at Nant Capital LLC. Jerel A. Banks is also on the board of Genos Research, Inc. and Aardvark Therapeutics, Inc.
He previously held the position of Vice President for Franklin Resources, Inc. Vice President & Portfolio Manager at Franklin Biotechnology Discovery Fund and Vice President of Franklin Advisers, Inc. (both are subsidiaries of Franklin Resources, Inc.), Principal at Apothecary Capital LLC, Senior Vice President-Mergers & Acquisitions at NantKwest, Inc., Financial Analyst for Sectoral Asset Management, Inc., Associate of Capital Research Co. (California) and Research Associate at Capital Research & Management Co.
Dr. Banks received a doctorate from Brown University, an undergraduate degree from Princeton University and a doctorate from The Warren Alpert Medical School.